Format

Send to

Choose Destination
Kidney Int. 2011 Feb;79(4):382-4. doi: 10.1038/ki.2010.474.

Raging hormones: gender and renal disease.

Author information

1
Department of Medicine, Montefiore Medical Center and the Albert Einstein College of Medicine, Bronx, New York 10467, USA. ssilbige@montefiore.org

Abstract

Gender affects the progression of renal disease. In a variety of animal models and in certain human renal diseases, females exhibit a more modest course of kidney disease. Estrogens and testosterone have been implicated in this gender disparity. Doublier and colleagues explore the direct effects of sex hormones on podocyte viability in the α-estrogen receptor knockout (αERKO) mouse. They report that testosterone induces, and estradiol inhibits, podocyte damage in this model.

PMID:
21278778
DOI:
10.1038/ki.2010.474
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center